Longan seed extract reduces hyperuricemia via modulating urate transporters and suppressing xanthine oxidase activity

American Journal of Chinese Medicine

Volumn 40, Issue 5, 2012, Pages 979-991

  Hou, Chien Wei ^a   Lee, Ying Chung ^b   Hung, Hsiao Fang ^c   Fu, Hua Wen ^c   Jeng, Kee Ching ^d  

^a YUANPEI UNIVERSITY   (Taiwan)

^b CHUNG CHOU INSTITUTE OF TECHNOLOGY   (Taiwan)

^c NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^d TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Gout; Hyperuricemia; Longan Seed Extract; Urate Transporters; Xanthine Oxidase

Indexed keywords

ALLOPURINOL; CORILAGIN; ELLAGIC ACID; GALLIC ACID; GLUCOSE TRANSPORTER 1; HYPOXANTHINE; LONGAN SEED EXTRACT; OTERACIL; PLANT EXTRACT; UNCLASSIFIED DRUG; URATE; URIC ACID; XANTHINE OXIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME REPRESSION; HYPERURICEMIA; IN VITRO STUDY; IN VIVO STUDY; KIDNEY; LIVER CELL; MALE; NONHUMAN; PLANT SEED; RAT; URIC ACID BLOOD LEVEL;

ALLOPURINOL; ANIMALS; GLUCOSE TRANSPORTER TYPE 1; GOUT; GOUT SUPPRESSANTS; HYPERURICEMIA; HYPOXANTHINE; KIDNEY; LIVER; MALE; MONOSACCHARIDE TRANSPORT PROTEINS; OXONIC ACID; PHYTOTHERAPY; PLANT EXTRACTS; POLYPHENOLS; RATS; RATS, SPRAGUE-DAWLEY; SAPINDACEAE; SEEDS; URIC ACID; XANTHINE OXIDASE;

EID: 84865755079     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X12500723     Document Type: Article

References (31)

1. Ahmad, N. S., M. Farman, M. H. Najmi, K. B. Mian and A. Hasan. Pharmacological basis for use of Pistacia integerrima leaves in hyperuricemia and gout. J. Ethnopharmacol. 117:478-482, 2008.
2. Borges, F., E. Fernandes and F. Roleira. Progress towards the discovery of xanthine oxidase inhibitors. Curr. Med. Chem. 9:195-217, 2001.
3. Burns, C. M. and R. L. Wortmann. Gout therapeutics: new drugs for an old disease. Lancet 377:97, 2010.
4. Carro, M. D., E. Falkenstein, W. J. Radke and H. Klandorf. Effects of allopurinol on uric acid concentrations, xanthine oxidoreductase activity and oxidative stress in broiler chickens. Comp. Biochem. Physiol. C 151:12-17, 2010.
5. Doherty, M. New insights into the epidemiology of gout. Rheumatology 48 S2: ii2-ii8, 2009.
6. Festa, F., T. Aglitti, G. Duranti, R. Ricordy, P. Perticone and R. Cozzi. Strong antioxidant activity of ellagic acid in mammalian cells in vitro revealed by the comet assay. Anticancer Res. 21:3903-3908, 2001.
7. Fields, M., C. G. Lewis and M. D. Lure. Allopurinol, an inhibitor of xanthine oxidase, reduces uric acid levels and modifies the signs associated with copper deficiency in rats fed fructose. Free Radic. Biol. Med. 20:595-600, 1996.
8. Haidari, F., M. R. Rashidi, S. A. Keshavarz, A. Mahboob, M. R. Eshraghian and M. M. Shahi. Effects of onion on serum uric acid levels and hepatic xanthine dehydrogenase/xanthine oxidase activities in hyperuricemic rats. Pak. J. Biol. Sci. 11:1779-1784, 2008.
9. Hsieh, C. Y. and S. T. Chang. Antioxidant activities and xanthine oxidase inhibitory effects of phenolic phytochemicals from Acacia confusa twigs and branches. J. Agric. Food Chem. 58:1578-1583, 2010.
10. Hu, Q. H., R. Q. Jiao, X. Wang, Y. Z. Lv and L. D. Kong. Simiao pill ameliorates urate underexcretion and renal dysfunction in hyperuricemic mice. J. Ethnopharmacol. 128:685-692, 2010.
11. Hung, S. I., W. H. Chung, L. B. Liou, C. C. Chu, M. Lin, H. P. Huang, Y. L. Lin, J. L. Lan, L. C. Yang, H. S. Hong, M. J. Chen, P. C. Lai, M. S. Wu, C. Y. Chu, K. H. Wang, C. H. Chen, C. S. Fann, J. Y. Wu and Y. T. Chen. HLA-β 5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc. Natl. Acad. Sci. USA 102:4134-4139, 2005.
12. Kang, D. H., T. Nakagawa, L. Feng, S. Watanabe, L. Han, M. Mazzali, L. Truong, R. Harris and R. J. Johnson. A role for uric acid in the progression of renal disease. J. Am. Soc. Nephrol. 13:2888-2897, 2002.
13. Kawada, M., Y. Ohno, Y. Ri, T. Ikoma, H. Yuugetu, T. Asai, M. Watanabe, N. Yasuda, S. Akao, G. Takemura, S. Minatoguchi, K. Gotoh, H. Fujiwara and K. Fukuda. Anti-tumor effect of gallic acid on LL-2 lung cancer cells transplanted in mice. Anticancer Drugs 12:847-852, 2001.
14. Kong, L. D., Y. Cai, W. W. Huang, C. H. Cheng and R. X. Tan. Inhibition of xanthine oxidase by some Chinese medicinal plants used to treat gout. J. Ethnopharmacol. 73:199-207, 2000.
15. Lee, M. H., G. G. Graham, K. M. Williams and R. O. Day. A benefit-risk assessment of benzbromarone in the treatment of gout. Was its withdrawal from the market in the best interest of patients? Drug Saf. 31:643-665, 2008.
16. Lee, P. C. Effect of allopurinol treatment on tissue xanthine oxidase levels in mice. Arch. Biochem. Biophys. 157:322-323, 1973.
17. Lin, S. D., D. H. Tsai and S. R. Hsu. Association between serum uric acid level and components of the metabolic syndrome. J. Chin. Med. Assoc. 69:512-516, 2006.
18. Losso, J. N., R. R. Bansode, A. Trappey, H. A. Bawadi and R. Truax. In vitro anti-proliferative activities of ellagic acid. J. Nutr. Biochem. 15:672-678, 2004.
19. Massey, V., P. E. Brumby and H. Koma. Studies on milk xanthine oxidase. Some spectral and kinetic properties. J. Biol. Chem. 244:1682-1691, 1969.
20. Mikuls, T. R., J. T. Farrar, W. B. Bilker, S. Fernandes, H. R. Jr. Schumacher and K. G. Saag. Gout epidemiology: results from the UK General Practice Research Database, 1990-1999. Ann. Rheum. Dis. 64:267-272, 2005.
21. Pacher, P., A. Nivorozhkin and C. Szabó. Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol. Rev. 58:87-114, 2006.
22. Pascual, E. and M. Perdiguero. Gout, diuretics and the kidney. Ann. Rheum. Dis. 65:981-982, 2006.
23. Preitner, F., O. Bonny, A. Laverrière, S. Rotman, D. Firsov, A. Da Costa, S. Metref and B. Thorens. Glut9 is a major regulator of urate homeostasis and its genetic inactivation induces hyperuricosuria and urate nephropathy. Proc. Natl. Acad. Sci. USA 106:15501-15506, 2009.
24. Rangkadilok, N., L. Worasuttayangkurn, R. N. Bennett and J. Satayavivad. Identification and quantification of polyphenolic compounds in Longan (Euphoria longana Lam.) fruit. J. Agric. Food Chem. 53:1387-1392, 2005.
25. Rangkadilok, N., S. Sitthimonchai, L. Worasuttayangkurn, C. Mahidol, M. Ruchirawat and J. Satayavivad. Evaluation of free radical scavenging and antityrosinase activities of standardized longan fruit extract. Food Chem. Toxicol. 45:328-336, 2007.
26. So, A. and B. Thorens. Uric acid transport and disease. J. Clin. Invest. 120:1791-1799, 2010.
27. Unno, T., A. Sugimoto and T. Kakuda. Xanthine oxidase inhibitors from the leaves of Lagerstroemia speciosa (L.) Pers. J. Ethnopharmacol. 93:391-395, 2004.
28. Urano, W., A. Taniguchi, N. Anzai, E. Inoue, C. Sekita, H. Endou, N. Kamatani and H. Yamanaka. Association between GLUT9 and gout in Japanese men. Ann. Rheum. Dis. 69:932-933, 2010.
29. Wen, C. P., T. Y. David-Cheng, H. T. Chan, M. K. Tsai, W. S. Chung, S. P. Tsai, M. L. Wahlqvist, Y. C. Yang, S. B. Wu, P. H. Chiang and S. F. Wen. Is high serum uric acid a risk marker or a target for treatment? Examination of its independent effect in a large cohort with low cardiovascular risk. Am. J. Kidney Dis. 56:273-288, 2010.
30. Yilmaz, Y. and R. T. Toledo. Major flavonoids in grape seeds and skins: antioxidant capacity of catechin, epicatechin, and gallic acid. J. Agric. Food Chem. 52:255-260, 2004.
31. Zakaria, Z. A., A. M. Mohamed, N. S. Jamil, M. S. Rofiee, M. K. Hussain, M. R. Sulaiman, L. K. Teh and M. Z. Salleh. In vitro antiproliferative and antioxidant activities of the extracts of Muntingia calabura leaves. Am. J. Chin. Med. 39:183-200, 2011.